Roivant Sciences Retained Earnings increased by 27.8% to -$501.81M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 532.4%, from $116.06M to -$501.81M. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows an upward trend with a -23.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals strong historical profitability and reinvestment, while a decrease may indicate losses or significant dividend payouts.
This represents the cumulative net income earned by the company since its inception, minus any dividends paid to shareho...
A key metric for all established companies; growth rates are compared against peers to gauge long-term success.
retained_earnings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.00B | -$2.21B | -$2.49B | -$2.76B | -$3.10B | -$3.39B | -$3.74B | -$3.77B | -$4.06B | -$4.37B | $727.29M | $576.17M | $671.47M | $395.58M | $460.40M | $116.06M | -$315.59M | -$429.11M | -$695.00M | -$501.81M |
| QoQ Change | — | -10.4% | -12.9% | -10.8% | -12.0% | -9.4% | -10.4% | -0.9% | -7.7% | -7.5% | +116.6% | -20.8% | +16.5% | -41.1% | +16.4% | -74.8% | -371.9% | -36.0% | -62.0% | +27.8% |
| YoY Change | — | — | — | — | -54.7% | -53.3% | -49.9% | -36.5% | -31.3% | -29.0% | +119.5% | +115.3% | +116.5% | +109.1% | -36.7% | -79.9% | -147.0% | -208.5% | -251.0% | -532.4% |